KLK3 and posterior cortical atrophy: As a high-quality disease-specific register [20,21], the NPCR has near-complete detailed data for the population on diagnostic characteristics, including clinical stage and PSA levels for newly diagnosed PCa patients, which is often limited in other large/national cancer incidence registers, e.g., SEER registries [43].